<?xml version='1.0' encoding='utf-8'?>
<document id="31919994"><sentence text="Physiologically-Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan."><entity charOffset="100-110" id="DDI-PubMed.31919994.s1.e0" text="Olanzapine" /><entity charOffset="115-126" id="DDI-PubMed.31919994.s1.e1" text="Samidorphan" /><pair ddi="false" e1="DDI-PubMed.31919994.s1.e0" e2="DDI-PubMed.31919994.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s1.e0" e2="DDI-PubMed.31919994.s1.e1" /></sentence><sentence text="A combination of the antipsychotic olanzapine and the opioid receptor antagonist samidorphan (OLZ/SAM) is intended to provide the antipsychotic efficacy of olanzapine while mitigating olanzapine-associated weight gain"><entity charOffset="35-45" id="DDI-PubMed.31919994.s2.e0" text="olanzapine" /><entity charOffset="54-60" id="DDI-PubMed.31919994.s2.e1" text="opioid" /><entity charOffset="81-92" id="DDI-PubMed.31919994.s2.e2" text="samidorphan" /><entity charOffset="94-97" id="DDI-PubMed.31919994.s2.e3" text="OLZ" /><entity charOffset="98-101" id="DDI-PubMed.31919994.s2.e4" text="SAM" /><entity charOffset="156-166" id="DDI-PubMed.31919994.s2.e5" text="olanzapine" /><entity charOffset="184-194" id="DDI-PubMed.31919994.s2.e6" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e0" e2="DDI-PubMed.31919994.s2.e6" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e1" e2="DDI-PubMed.31919994.s2.e6" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e2" e2="DDI-PubMed.31919994.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e2" e2="DDI-PubMed.31919994.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e2" e2="DDI-PubMed.31919994.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e2" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e2" e2="DDI-PubMed.31919994.s2.e6" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e3" e2="DDI-PubMed.31919994.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e3" e2="DDI-PubMed.31919994.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e3" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e3" e2="DDI-PubMed.31919994.s2.e6" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e4" e2="DDI-PubMed.31919994.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e4" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e4" e2="DDI-PubMed.31919994.s2.e6" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e5" e2="DDI-PubMed.31919994.s2.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s2.e5" e2="DDI-PubMed.31919994.s2.e6" /></sentence><sentence text=" As cytochrome P450 (CYP) 1A2 and CYP3A4 are the major enzymes involved in metabolism of olanzapine and samidorphan, respectively, physiologically-based pharmacokinetic (PBPK) modeling was applied to predict any drug-drug interaction (DDI) potential between olanzapine and samidorphan or between OLZ/SAM and CYP3A4/CYP1A2 inhibitors/inducers"><entity charOffset="89-99" id="DDI-PubMed.31919994.s3.e0" text="olanzapine" /><entity charOffset="104-115" id="DDI-PubMed.31919994.s3.e1" text="samidorphan" /><entity charOffset="258-268" id="DDI-PubMed.31919994.s3.e2" text="olanzapine" /><entity charOffset="273-284" id="DDI-PubMed.31919994.s3.e3" text="samidorphan" /><entity charOffset="296-306" id="DDI-PubMed.31919994.s3.e4" text="OLZ" /><entity charOffset="300-310" id="DDI-PubMed.31919994.s3.e5" text="SAM" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e0" e2="DDI-PubMed.31919994.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e1" e2="DDI-PubMed.31919994.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e1" e2="DDI-PubMed.31919994.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e1" e2="DDI-PubMed.31919994.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e1" e2="DDI-PubMed.31919994.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e1" e2="DDI-PubMed.31919994.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e2" e2="DDI-PubMed.31919994.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e2" e2="DDI-PubMed.31919994.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e2" e2="DDI-PubMed.31919994.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e2" e2="DDI-PubMed.31919994.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e3" e2="DDI-PubMed.31919994.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e3" e2="DDI-PubMed.31919994.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e3" e2="DDI-PubMed.31919994.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e4" e2="DDI-PubMed.31919994.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31919994.s3.e4" e2="DDI-PubMed.31919994.s3.e5" /></sentence><sentence text=" A PBPK model for OLZ/SAM was developed and validated by comparing model-simulated data with observed clinical study data"><entity charOffset="18-20" id="DDI-PubMed.31919994.s4.e0" text="OLZ" /><entity charOffset="22-24" id="DDI-PubMed.31919994.s4.e1" text="SAM" /><pair ddi="false" e1="DDI-PubMed.31919994.s4.e0" e2="DDI-PubMed.31919994.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s4.e0" e2="DDI-PubMed.31919994.s4.e1" /></sentence><sentence text=" Based on model-based simulations, no DDI between olanzapine and samidorphan is expected when administered as OLZ/SAM"><entity charOffset="50-60" id="DDI-PubMed.31919994.s5.e0" text="olanzapine" /><entity charOffset="65-76" id="DDI-PubMed.31919994.s5.e1" text="samidorphan" /><entity charOffset="110-120" id="DDI-PubMed.31919994.s5.e2" text="OLZ" /><entity charOffset="114-124" id="DDI-PubMed.31919994.s5.e3" text="SAM" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e0" e2="DDI-PubMed.31919994.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e0" e2="DDI-PubMed.31919994.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e0" e2="DDI-PubMed.31919994.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e0" e2="DDI-PubMed.31919994.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e1" e2="DDI-PubMed.31919994.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e1" e2="DDI-PubMed.31919994.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e1" e2="DDI-PubMed.31919994.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e2" e2="DDI-PubMed.31919994.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31919994.s5.e2" e2="DDI-PubMed.31919994.s5.e3" /></sentence><sentence text=" CYP3A4 inhibition is predicted to have a weak effect on samidorphan exposure and negligible effect on olanzapine exposure"><entity charOffset="57-68" id="DDI-PubMed.31919994.s6.e0" text="samidorphan" /><entity charOffset="103-113" id="DDI-PubMed.31919994.s6.e1" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.31919994.s6.e0" e2="DDI-PubMed.31919994.s6.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s6.e0" e2="DDI-PubMed.31919994.s6.e1" /></sentence><sentence text=" CYP3A4 induction is predicted to reduce both samidorphan and olanzapine exposure"><entity charOffset="46-57" id="DDI-PubMed.31919994.s7.e0" text="samidorphan" /><entity charOffset="62-72" id="DDI-PubMed.31919994.s7.e1" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.31919994.s7.e0" e2="DDI-PubMed.31919994.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31919994.s7.e0" e2="DDI-PubMed.31919994.s7.e1" /></sentence><sentence text=" CYP1A2 inhibition or induction is predicted to increase or decrease, respectively, olanzapine exposure only"><entity charOffset="84-94" id="DDI-PubMed.31919994.s8.e0" text="olanzapine" /></sentence><sentence text="" /></document>